NFKB1 and arthritic joint disease: One of the imidazole‐containing mimetics, the (R)‐epimer of 6C‐dimethylimidazole (AT‐01‐KG), significantly attenuated NF‐κB activity in vitro and displayed significant anti‐inflammatory and pre‐resolving effects in a range of inflammatory models (e.g. peritonitis, arthritis and paw swelling) in vivo at picomolar concentrations (Galvao et al., 2021).